Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.

Details

Serval ID
serval:BIB_D910A818B30C
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.
Journal
Clinical Cancer Research
Author(s)
Romano E., Rossi M., Ratzinger G., de Cos M.A., Chung D.J., Panageas K.S., Wolchok J.D., Wolchock J.D., Houghton A.N., Chapman P.B., Heller G., Yuan J., Young J.W.
ISSN
1078-0432 (Print)
ISSN-L
1078-0432
Publication state
Published
Issued date
2011
Volume
17
Number
7
Pages
1984-1997
Language
english
Notes
Publication types: Clinical Trial, Phase I ; Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Keywords
Adult, Aged, Aged, 80 and over, Antigens, CD3/metabolism, Antigens, CD8/metabolism, Antigens, Neoplasm/immunology, Apoptosis/drug effects, Cancer Vaccines/adverse effects, Cancer Vaccines/therapeutic use, Dendritic Cells/drug effects, Dendritic Cells/immunology, Drug Synergism, Erythema/etiology, Female, HLA-A Antigens/metabolism, Humans, Immunotherapy, Active, Interferon-gamma/secretion, Interleukin-15/immunology, Interleukin-15/pharmacology, Interleukin-2/immunology, Interleukin-2/pharmacology, Langerhans Cells/drug effects, Langerhans Cells/immunology, Lymphocyte Activation, Male, Melanoma/immunology, Melanoma/therapy, Middle Aged, T-Lymphocytes, Cytotoxic/immunology, T-Lymphocytes, Cytotoxic/physiology, T-Lymphocytes, Regulatory/drug effects, T-Lymphocytes, Regulatory/physiology
Pubmed
Web of science
Create date
25/10/2011 14:17
Last modification date
20/08/2019 16:58
Usage data